Abstract
A 58-year-old previously healthy man presented with diplopia of rapid onset over a few days. Examination demonstrated bilateral sixth and right fourth cranial nerve palsy. MR imaging showed a large sellar mass with significant destruction of the pituitary fossa. Laboratory tests revealed very high serum prolactin (2,483 ng/dl, reference range 3–13 ng/dl). Dopamine agonist therapy was initiated with significant decline in PRL levels; however, nausea, fatigue, and anorexia developed. Within a few weeks the patient developed renal failure and hypercalcemia. Urine protein electrophoresis revealed large free monoclonal kappa peaks while extensive plasmocytosis was evident in bone marrow aspirates. On bone scan numerous lytic lesions were present. A transsphenoidal excisional biopsy was performed which demonstrated two distinct populations of cells, corresponding to a plasma cell tumor and a lactotroph adenoma. Treatment for multiple myeloma was initiated along with radiotherapy for the sellar tumor. Only a few cases of solitary plasmocytomas of the pituitary region have been reported. Few cases of prolactinomas coexisting with other sellar tumors has been described. We discuss in this report possible pathogenic and functional connections between these two tumors. We suggest that in the presence of extensive cranial nerve involvement, atypical imaging findings for a pituitary adenoma and severe hyperprolactinemia, the possibility of a collision tumor should lead the physician to consider excisional tumor biopsy or surgery in addition to dopamine agonist therapy.
References
Sinnott BP, Hatipoglu B, Sarne DH (2006) Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: case report & literature review. Pituitary 9:65–72. doi:10.1007/s11102-006-8281-9
Puchner MJA, Herrmann H-D (1998) Intrasellar pituitary gangliocyto-adenoma presenting with acromegaly: case report. Neurosurgery 42:1197–1199. doi:10.1097/00006123-199805000-00165
Syro LV, Horvath E, Kovacs K (2000) Double adenoma of the pituitary: a somatotroph adenoma colliding with a gonadotroph adenoma. J Endocrinol Invest 23:37–41
Karavitaki N, Scheithauer B, Watt J, Ansorge O, Moschopoulos M, Llaguno A et al (2008) Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke’s cleft cyst with corticotroph adenoma. Pituitary 11:317–323. doi:10.1007/s11102-007-0070-6
Ben-Jonathan N, Hugo ER, Brandebourg TD, LaPensee CR (2006) Focus on prolactin as a metabolic hormone. Trends Endocrinol Metab 17:110–116. doi:10.1016/j.tem.2006.02.005
Harris J, Stanford PM, Oakes SR, Ormandy CJ (2004) Prolactin and the prolactin receptor: new targets of an old hormone. Ann Med 36:414–425. doi:10.1080/07853890410033892
Gadó KNG, Hasitz A, Tóth BE, Rimanóczi E, Domján G (2001) Evidence of prolactin immunoreactivity in the bone marrow of untreated multiple myeloma patients. Neuroimmunomodulation 9:95–102. doi:10.1159/000049012
Gado K, Pallinger E, Kovacs P, Takacs E, Szilvasi I, Toth BE et al (2002) Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. Immunol Lett 82:191–196. doi:10.1016/S0165-2478(02)00008-1
Gadó K, Rimanóczi É, Hasitz Á, Gigler G, Tóth BE, Nagy GM et al (2001) Elevated levels of serum prolactin in patients with advanced multiple myeloma. Neuroimmunomodulation 9:231–236. doi:10.1159/000049031
Gandhi GY, Basu R, Dispenzieri A, Basu A, Montori VM, Brennan MD (2007) Endocrinopathy in POEMS syndrome: the Mayo Clinic experience. Mayo Clin Proc 82:836–842
Reulecke M, Dumas M, Meier C (1988) Specific antibody activity against neuroendocrine tissue in a case of POEMS syndrome with IgG gammopathy. Neurology 38:614–616
Dispenzieri A (2007) POEMS syndrome. Blood Rev 21:285–299. doi:10.1016/j.blre.2007.07.004
Losa M, Terreni MR, Tresoldi M, Marcatti M, Campi A, Triulzi F et al (1992) Solitary plasmacytoma of the sphenoid sinus involving the pituitary fossa: a case report and review of the literature. Surg Neurol 35:388–393. doi:10.1016/0090-3019(92)90010-K
McLaughlin DM, Gray WJ, Jones FGC, Mirakhur M, McCance DR, Sheridan B et al (2004) Plasmacytoma: an unusual cause of a pituitary mass lesion. A case report and a review of the literature. Pituitary 7:179–181. doi:10.1007/s11102-005-1758-0
Sanchez JA, Rahman S, Strauss RA, Kaye GI (1977) Multiple myeloma masquerading as a pituitary tumor. Arch Pathol Lab Med 101:55–56
Weber J, Jaksche H (1999) Solitary plasmacytoma of the pituitary area. Acta Neurochir 141:219–220. doi:10.1007/s007010050291
Peeva E, Venkatesh J, Michael D, Diamond B (2004) Prolactin as a modulator of B cell function: implications for SLE. Biomed Pharmacother 58:310–319. doi:10.1016/j.biopha.2004.04.007
McMurray RW (2001) Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum 31:21–32. doi:10.1053/sarh.2001.25482
Orbach H, Shoenfeld Y (2007) Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 6:537–542. doi:10.1016/j.autrev.2006.10.005
Klein B, Zhang XG, Lu ZY, Bataille R (1995) Interleukin-6 in human multiple myeloma. Blood 85:863–872
Clevenger CV (2003) Role of prolactin/prolactin receptor signaling in human breast cancer. Breast Dis 18:75–86
Author information
Authors and Affiliations
Corresponding author
Additional information
Synnove Alves is a Visiting Medical Student at the McGill University Health Center.
Rights and permissions
About this article
Cite this article
Rivera, J., Alves, S., Bianchi, C.C. et al. An unusual collision tumor comprising a prolactinoma and a plasmocytoma originating from the sellar region. Pituitary 13, 189–193 (2010). https://doi.org/10.1007/s11102-008-0145-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-008-0145-z